Re: interesting article on Sriram

[Guest guest]

Is that an old article? It was dated 2000.

Did you notice that Chuck Stratton is his buddy?

>

> http://weeklywire.com/ww/02-14-00/nash_cover.html

>

[Guest guest]

Yes, old article. Yes, Stratton and Sriram have published together

several times, both are at Vanderbilt. Unfortunately, one or both of

them did a 6-month combo abx trial for MS, published last summer,

where reductions in new lesion growth werent statistically significant

(tho some other disease measure did achieve significance). I think

part of their problem achieving statistical significance re the

lesions was the small size (4 in treatment group, 4 in control group).

No one wants to be in a long-term MS study where they may be recieving

placebo.

> >

> > http://weeklywire.com/ww/02-14-00/nash_cover.html

> >

>

[Guest guest]

Have they done a study on CFIDS?

Marie <usenethod@...> wrote:

Yes, old article. Yes, Stratton and Sriram have published together several times, both are at Vanderbilt. Unfortunately, one or both of them did a 6-month combo abx trial for MS, published last summer, where reductions in new lesion growth werent statistically significant (tho some other disease measure did achieve significance). I think part of their problem achieving statistical significance re the lesions was the small size (4 in treatment group, 4 in control group). No one wants to be in a long-term MS study where they may be recieving placebo.> >> > http://weeklywire.com/ww/02-14-00/nash_cover.html> >>

FareChase - Search multiple travel sites in one click.